Symptomatic people with evidence of coronary artery disease on imaging significantly benefited from statin use while those ...

Please provide your email address to receive an email when new articles are posted on . Ten-year predicted ASCVD risk of 4% or more may serve as an adequate threshold for statin initiation based on ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

For some people with high cholesterol, making lifestyle changes and taking routine statin medications may not be sufficient ...

Are you among the 73 million Americans with cholesterol levels that current guidelines suggest should be lowered by taking a statin for the sake of your cardiovascular well-being? Have you and your ...

Statin therapy demonstrated a dose-dependent increase in the risk for new-onset diabetes, especially among individuals already at high risk for diabetes. Higher doses of statin therapy moderately ...

There is decreased risk for venous thromboembolism in women aged 50 to 64 years receiving hormone therapy and statin therapy. Statin therapy is associated with a decreased risk for venous ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Pharmaceutical company Merck has created a new pill called enlicitide, which promises to lower "bad" cholesterol as ...

The drug enlicitide reduced cholesterol for adults with high levels due to an inherited disorder and may also work for a broader population.

A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol ...